<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20260630070020N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-07-09</date_registration>
      <primary_sponsor>Yasouj University of Medical Sciences</primary_sponsor>
      <public_title>Effect of Safflower Oil on Postoperative Wounds Following Pilonidal Cyst Surgery</public_title>
      <acronym></acronym>
      <scientific_title>The Effect of Topical Safflower (Carthamus tinctorius L.) Seed Oil on Open Wound Healing in Patients with Pilonidal Sinus Following Surgery: A Randomized Controlled Clinical TriaL</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2026-08-06</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>60</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/91371</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Participants in this study will be allocated to the intervention and control groups using **block randomization** with **individual randomization** as the unit of randomization. To ensure balanced group sizes and reduce the predictability of treatment allocation, **random blocks of variable sizes (2, 4, 6, and 8)** will be used. **Stratified randomization** will not be applied. The random allocation sequence will be generated using the **Sealed Envelope** website, and participants will be assigned to either the intervention group (A) or the control group (B) according to the generated sequence. To ensure **allocation concealment**, the randomization sequence will be maintained by an independent third party, and a unique study code will be assigned to each participant before enrollment, ensuring that the researcher remains unaware of the participant's treatment allocation until the time of assignment, Blinding description: In this study, patient blinding will not be performed. Because the comparison will be made with the standard treatment, which only includes washing and dressing, and the use of ointment has no place in the standard treatment. However, the blinding of the evaluator will be performed. In this way, the patients will be fully aware in advance that they will not provide the evaluator with information about their treatment during periodic assessments, and the evaluator will not ask about the type of treatment of the patients during periodic assessments. At the beginning of the study, the third party will provide each patient with a unique code, then record the information related to the patient's allocation to one of the study groups along with the unique code, and at the end of the study, after data collection, the recorded information will be made available to the researcher for data analysis.</study_design>
      <phase>2-3</phase>
      <hc_freetext>Pilonidal cyst.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: In addition to standard treatment, patients will receive topical safflower seed oil (Carthamus tinctorius). After washing the wound daily, approximately a fingertip of the oil is placed on a gauze pad and applied to the wound bed, followed by a dressing. The dressing will be changed every 24 hours for the first week and every 48 hours from the second week onwards for a period of 4 weeks. Intervention 2: Control group: Patients will receive standard wound care, which includes daily irrigation of the wound with normal saline and dressing with plain sterile gauze, without the use of safflower seed oil or other topical products. The dressing will be changed every 24 hours for the first week and every 48 hours from the second week onwards for a period of 4 weeks.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
After the completion of the study, all study data will be shared after being de-identified

When:
One month after the completion of the intervention, the data of the main variables of the study will be shared

To whom:
After The Publication Of The Article, all individuals will have access to its content

Conditions:
Individuals associated with the medical and therapeutic fields may utilize the data from this study to conduct new research

Where to obtain:
Via official email to the corresponding author at: r_hosseinpour@yahoo.com.

How to obtain:
The applicant must submit their formal request via the organization's email to the responsible author's email address. The accountable author will provide the information to the applicant within a maximum of 2 weeks after the applicant confirms the information.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Ali Keshvari Khanimeni</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shahid Zarei Educational Campus, Beach Park Towards Imam Sajjad (AS) Hospital, Yasuj</address>
        <city>Yasuj</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7591875111</zip>
        <telephone>+98 74 3323 5153</telephone>
        <email>Alikeshvari0060@gmail.com</email>
        <affiliation>Yasouj University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Reza Hossein-pour</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shahid Zarei Educational Campus, Beach Park Towards Imam Sajjad (AS) Hospital, Yasuj</address>
        <city>Yasuj</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7591875111</zip>
        <telephone>+98 74 3332 5153</telephone>
        <email>r_hosseinpour@yahoo.com</email>
        <affiliation>Yasouj University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Definitive diagnosis of pilonidal disease by a surgeon and open excision surgery
Absence of clinical signs of active wound infection at the time of study entry</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>60 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Having diabetes
History of clotting disorders or deep vein thrombosis</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>L05</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Pilonidal cyst and sinus</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: In addition to standard treatment, patients will receive topical safflower seed oil (Carthamus tinctorius). After washing the wound daily, approximately a fingertip of the oil is placed on a gauze pad and applied to the wound bed, followed by a dressing. The dressing will be changed every 24 hours for the first week and every 48 hours from the second week onwards for a period of 4 weeks.</i_keyword>
      <i_keyword>Control group: Patients will receive standard wound care, which includes daily irrigation of the wound with normal saline and dressing with plain sterile gauze, without the use of safflower seed oil or other topical products. The dressing will be changed every 24 hours for the first week and every 48 hours from the second week onwards for a period of 4 weeks.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pain intensity. Timepoint: Before and after the intervention. Method of measurement: Using a visual analog scale (VAS).</prim_outcome>
      <prim_outcome>Wound healing time. Timepoint: After the intervention. Method of measurement: Using the PUSH scale.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Yasouj University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2026-05-20</approval_date>
        <contact_name>Ethics committee of Yasuj University of Medical Sciences</contact_name>
        <contact_address>Daneshgah St., Motahari Blvd., Jahad Town Yasuj Kohgilouyeh-va-Boyrahmad Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
